Thank you for your inquiry about CMS130v14 (performance period 2026). This measure is based on the U.S. Preventive Services Task Force (USPSTF) guidelines which does not include ColoSense as an applicable screening test, therefore it does not meet measure criteria. Applicable screenings to meet the numerator criteria may include Fecal Occult Blood Test, Stool DNA with Fecal Immunochemical Test (FIT), Flexible Sigmoidoscopy, CT Colonography, or a colonoscopy. FIT-DNA tests during the measurement period or the two years prior to the measurement period would qualify for the Numerator criteria. In the measure specification, qualifying FIT-DNA tests are defined by the codes listed in the following value set "FIT DNA", i.e., LOINC 77353-1 (Noninvasive colorectal cancer DNA and occult blood screening [Interpretation] in Stool Narrative) and LOINC 77354-9 (Noninvasive colorectal cancer DNA and occult blood screening [Presence] in Stool).